Skip to content

ViOph.arma: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

ViOph.arma

BE 0457.301.055
NACE 47.730, Retail sale of pharmaceutical products
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€61,723
2024 · €70,878-€9,155
Equity
€406,053
2024 · €399,331+€6,723
Cash
€242,057
2024 · €213,773+€28,284
Balance sheet total
€689,435
2024 · €664,814+€24,621

Largest movements

2024 to 2025
Assets
  • Cash +€28,284

    up €28,284 (+13.2%), from €213,773 to €242,057

    mainly Net result for the year (+€61,723) and Depreciation (+€26,761)

  • Intangible fixed assets -€17,166

    down €17,166 (-22.6%), from €76,064 to €58,897

  • Receivables within one year +€13,701

    up €13,701 (+14.9%), from €92,008 to €105,709

    of which Trade receivables: +€6,884

  • Tangible fixed assets -€9,595

    down €9,595 (-7.4%), from €129,930 to €120,336

    of which Plant, machinery and equipment: -€5,320

  • Stocks and contracts +€8,657

    up €8,657 (+5.8%), from €148,901 to €157,558

Equity and liabilities
  • Other debts +€15,012

    up €15,012 (+25.4%), from €59,052 to €74,064

  • Debts after one year -€12,114

    down €12,114 (-35.0%), from €34,582 to €22,468

  • Trade debts +€9,144

    up €9,144 (+7.5%), from €122,274 to €131,419

Income statement
  • Gross operating margin -€7,164

    down €7,164 (-2.8%), from €260,073 to €252,910

  • Staff costs +€6,658

    up €6,658 (+5.0%), from €133,455 to €140,113

  • Taxes -€2,979

    down €2,979 (-11.7%), from €25,427 to €22,448

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €70,878
Gross operating margin -€7,164
Staff costs -€6,658
Depreciation -€337
Other operating charges -€38
Other operating items +€1,600
Financial income +€397
Financial charges +€66
Taxes +€2,979
Result 2025 €61,723

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€95,421
Investment €0
Financing -€67,137
Cash 2024 €213,773
Net result for the year +€61,723
Depreciation +€26,761
Stocks and contracts -€8,657
Receivables within one year -€13,701
Deferred charges and accrued income -€741
Trade debts +€9,144
Tax, wage and social debts +€32
Other debts +€15,012
Accrued charges and deferred income +€5,848
Debts after one year -€12,114
Current portion of long-term debt -€23
Contributions, distributions and other -€55,000
Cash 2025 €242,057
Every line side by side 48 lines
Line Code 2024 2025 Change %
Total assets 20/58 €664,814 €689,435 +€24,621 +3.7%
Fixed assets 21/28 €205,994 €179,233 -€26,761 -13.0%
Intangible fixed assets 21 €76,064 €58,897 -€17,166 -22.6%
Tangible fixed assets 22/27 €129,930 €120,336 -€9,595 -7.4%
Land and buildings 22 €86,549 €82,731 -€3,818 -4.4%
Plant, machinery and equipment 23 €42,459 €37,138 -€5,320 -12.5%
Furniture and vehicles 24 €922 €466 -€456 -49.5%
Current assets 29/58 €458,820 €510,202 +€51,382 +11.2%
Stocks and contracts in progress 3 €148,901 €157,558 +€8,657 +5.8%
Stocks 30/36 €148,901 €157,558 +€8,657 +5.8%
Amounts receivable within one year 40/41 €92,008 €105,709 +€13,701 +14.9%
Trade receivables 40 €85,752 €92,636 +€6,884 +8.0%
Other amounts receivable 41 €6,256 €13,073 +€6,817 +109.0%
Cash at bank and in hand 54/58 €213,773 €242,057 +€28,284 +13.2%
Deferred charges and accrued income 490/1 €4,138 €4,879 +€741 +17.9%
Total equity and liabilities 10/49 €664,814 €689,435 +€24,621 +3.7%
Equity 10/15 €399,331 €406,053 +€6,723 +1.7%
Contributions 10/11 €62,000 €62,000 = 0.0%
Reserves 13 €6,200 €6,200 = 0.0%
Non-distributable reserves 130/1 €6,200 €6,200 = 0.0%
Reserves not available under the articles 1311 €6,200 €6,200 = 0.0%
Profit (loss) carried forward 14 €331,131 €337,853 +€6,723 +2.0%
Amounts payable 17/49 €265,484 €283,382 +€17,899 +6.7%
Amounts payable after more than one year 17 €34,582 €22,468 -€12,114 -35.0%
Financial debts 170/4 €34,582 €22,468 -€12,114 -35.0%
Amounts payable within one year 42/48 €230,880 €255,044 +€24,164 +10.5%
Current portion of amounts payable after more than one year 42 €20,470 €20,447 -€23 -0.1%
Trade debts 44 €122,274 €131,419 +€9,144 +7.5%
Suppliers 440/4 €122,274 €131,419 +€9,144 +7.5%
Taxes, remuneration and social security 45 €29,083 €29,115 +€32 +0.1%
Taxes 450/3 €5,412 €7,049 +€1,637 +30.3%
Remuneration and social security 454/9 €23,671 €22,066 -€1,606 -6.8%
Other amounts payable 47/48 €59,052 €74,064 +€15,012 +25.4%
Accrued charges and deferred income 492/3 €21 €5,869 +€5,848 +27314.3%
Remuneration, social security and pensions 62 €133,455 €140,113 +€6,658 +5.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €26,424 €26,761 +€337 +1.3%
Other operating charges 640/8 €1,354 €1,392 +€38 +2.8%
Non-recurring operating charges 66A €1,600 - -€1,600
Gross operating margin 9900 €260,073 €252,910 -€7,164 -2.8%
Operating profit (loss) 9901 €97,240 €84,644 -€12,596 -13.0%
Financial income 75/76B €1,046 €1,443 +€397 +37.9%
Recurring financial income 75 €1,046 €1,443 +€397 +37.9%
Financial charges 65/66B €1,982 €1,916 -€66 -3.3%
Recurring financial charges 65 €1,982 €1,916 -€66 -3.3%
Profit (loss) for the period before taxes 9903 €96,304 €84,171 -€12,133 -12.6%
Income taxes 67/77 €25,427 €22,448 -€2,979 -11.7%
Profit (loss) for the period 9904 €70,878 €61,723 -€9,155 -12.9%
Profit (loss) for the period to be appropriated 9905 €70,878 €61,723 -€9,155 -12.9%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 5 October 2026 via checked.be.